Hiroya Kitsunai

7PUBLICATIONS
6CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsBehavioural epidemiologyMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 25, 2026
Linagliptin increases the expression of LRP2 independent of Nrf2 in streptozotocin-induced diabetic mice.

|Sep 25, 2026
Effect of pemafibrate on LDL-cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM-T2D post hoc analysis.

|Jul 15, 2026
Real-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

|Apr 07, 2026
Real-World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido-TZP Study.

Fumika Maruyama, Hiroya Kitsunai, Naoyuki Kitao

|Jan 25, 2025
The Effects of Oral Semaglutide on Hepatic Fibrosis in Subjects with Type 2 Diabetes in Real-World Clinical Practice: A Post Hoc Analysis of the Sapporo-Oral SEMA Study.

Hiroya Kitsunai, Yuka Shinozaki, Sho Furusawa

Pageof 2

Frequent Collaborators

6 joint publications

Hiroshi Nomoto

3 joint publications

Akinobu Nakamura

1 joint publications

Kyu Yong Cho

1 joint publications

So Nagai